These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. The role of endothelin in FK506-induced vascular reactivity changes in rat perfused kidney. Tekes E, Soydan G, Tuncer M. Eur J Pharmacol; 2005 Jul 04; 517(1-2):92-6. PubMed ID: 15964565 [Abstract] [Full Text] [Related]
9. The effect of an endothelin-receptor antagonist, bosentan, on blood pressure in patients with essential hypertension. Bosentan Hypertension Investigators. Krum H, Viskoper RJ, Lacourciere Y, Budde M, Charlon V. N Engl J Med; 1998 Mar 19; 338(12):784-90. PubMed ID: 9504938 [Abstract] [Full Text] [Related]
10. Beneficial hemodynamic effects of bosentan, a mixed ET(A) and ET(B) receptor antagonist, in portal hypertensive rats. Sogni P, Moreau R, Gomola A, Gadano A, Cailmail S, Calmus Y, Clozel M, Lebrec D. Hepatology; 1998 Sep 19; 28(3):655-9. PubMed ID: 9731554 [Abstract] [Full Text] [Related]
11. Investigation of the contributions of nitric oxide and prostaglandins to the actions of endothelins and sarafotoxin 6c in rat isolated perfused lungs. Lal H, Woodward B, Williams KI. Br J Pharmacol; 1996 Aug 19; 118(8):1931-8. PubMed ID: 8864526 [Abstract] [Full Text] [Related]
13. In vivo effects of endothelin-2, endothelin-3 and ETA receptor blockade on arterial, venous and capillary functions in cat skeletal muscle. Ekelund U. Acta Physiol Scand; 1994 Jan 19; 150(1):47-56. PubMed ID: 8135123 [Abstract] [Full Text] [Related]
15. Pharmacokinetics and pharmacodynamics of the endothelin-receptor antagonist bosentan in healthy human subjects. Weber C, Schmitt R, Birnboeck H, Hopfgartner G, van Marle SP, Peeters PA, Jonkman JH, Jones CR. Clin Pharmacol Ther; 1996 Aug 19; 60(2):124-37. PubMed ID: 8823230 [Abstract] [Full Text] [Related]
16. Influence of SQ 29,548 on vasoconstrictor responses in the mesenteric vascular bed of the cat. Minkes RK, Lippton HL, Armstead WM, Lepak KA, Higuera TR, McNamara DB, Kadowitz PJ. Eur J Pharmacol; 1990 Apr 10; 179(1-2):119-27. PubMed ID: 2364976 [Abstract] [Full Text] [Related]
17. Angiotensin II receptor blockade unmasks a depressor response to endothelin antagonists in rats. Richard V, Hogie M, Thuillez C. Fundam Clin Pharmacol; 2000 Apr 10; 14(2):101-6. PubMed ID: 10796056 [Abstract] [Full Text] [Related]
18. Analysis of the effects of candesartan in the mesenteric vascular bed of the cat. Champion HC, Kadowitz PJ. Hypertension; 1997 Nov 10; 30(5):1260-6. PubMed ID: 9369285 [Abstract] [Full Text] [Related]
19. Analysis of the inhibitory effects of DuP 753 and EXP 3174 on responses to angiotensin II in the feline hindquarters vascular bed. Osei SY, Minkes RK, Bellan JA, Kadowitz PJ. J Pharmacol Exp Ther; 1993 Mar 10; 264(3):1104-12. PubMed ID: 8450454 [Abstract] [Full Text] [Related]
20. Inhibitory effects of DuP 753 and EXP3174 on responses to angiotensin II in pulmonary vascular bed of the cat. McMahon TJ, Kaye AD, Hood JS, Minkes RK, Nossaman BD, Kadowitz PJ. J Appl Physiol (1985); 1992 Nov 10; 73(5):2054-61. PubMed ID: 1474085 [Abstract] [Full Text] [Related] Page: [Next] [New Search]